Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century

References

• Forstpointner R, Dreyling M, Repp R, . The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared to FCM alone in patients with refractory and relapsed follicular and mantle celllymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 2004;104:3064–3071.
   PubMed Web of Science ®Google Scholar
• Coiffier B. Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma. Semin Oncol 2002;29(Suppl. 6):18–22.
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Trumper L, Osterborg A, . CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379–391.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Ongoing improvement in outcomes for patients diagnosed as having non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med 2008;168:469–476.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy. Leuk Lymphoma 2009;50:179–186.
   PubMed Web of Science ®Google Scholar
• van de Schans SA, Gondos A, van Spronsen DJ, . Improving relative survival, but large remaining differences in survival for non-Hodgkin's lymphoma across Europe and the United States from 1990 to 2004. J Clin Oncol 2011;29:192–199.
   PubMed Web of Science ®Google Scholar
• Hiripi E, Gondos A, Emrich K, et al.;GEKID Cancer Survival Working Group.Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol 2012;23:472–479.
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Factors Project .A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987–994.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Available from: http://seer.cancer.gov/data/
   Google Scholar
• Mariotto A, Capocaccia R, Verdecchia A, . Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control 2002;13:101–111.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for up-to-date cancer survival data: theory, empirical evaluation, computational realization and applications. Eur J Cancer 2004;40: 326–335.
   PubMed Web of Science ®Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40:2307–2316.
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004–2010.
   PubMed Web of Science ®Google Scholar
• Brenner H, Soederman B, Hakulinen T. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 2002;31:456–462.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 2002;20: 826–832.
   PubMed Web of Science ®Google Scholar
• Brenner H, Hakulinen T. Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol 2006;164:689–696.
   PubMed Web of Science ®Google Scholar
• Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Bethesda, MD: National Cancer Institute; 1959.
   Google Scholar
• Arias E. United States life tables, 2000. Natl Vit Stat Rep 2002;51(3):1–39.
   PubMedGoogle Scholar
• Brenner H, Gefeller O, Hakulinen T. A computer program for period analysis of cancer patients survival. Eur J Cancer 2002;38:690–695.
   PubMed Web of Science ®Google Scholar
• Adamson P, Bray F, Constantini AS, . Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 2007;43:391–401.
   PubMed Web of Science ®Google Scholar
• Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004;23:6524–6534.
   PubMed Web of Science ®Google Scholar
• Morton LM, Wang SS, Devsa SS, . Lymphoma incidence patterns by WHO subtype in the United States 1992–2001. Blood 2006;107:265–276.
   PubMed Web of Science ®Google Scholar
• Sandin S, Hjealgrim H, Glimelius B, . Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was. Cancer Epidemiol Biomarkers Prev 2006;15:1295–1300.
   PubMed Web of Science ®Google Scholar
• Balduci L, Al-Halawani H, Charu V, . Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 2007;12:1214–1224.
   Google Scholar
• Marcos-Gragera R, Allemani C, Tereanu C, . Survival of European patients diagnosed with lymphoid neoplasms in 2000–2002: results of the HAEMACARE project. Haematologica 2011;96:720–728.
   PubMed Web of Science ®Google Scholar
• Jayasekara H, Karahalios A, Juneja S, . Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia. Leuk Lymphoma 2010;51: 456–468.
   PubMed Web of Science ®Google Scholar
• Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990–2004. J Natl Cancer Inst 2008;100:1301–1309.
   PubMed Web of Science ®Google Scholar
• Epidemiologisches Bulletin Nr 46. Robert Koch Institut Epidemiol Bull 2010;46:453–462.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). HIV prevalence estimates--United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1073–1076.
   PubMedGoogle Scholar
• Mumby PB, Hurley C, Samsi M, . Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants. Bone Marrow Transplant 2012;47:556–561.
   PubMed Web of Science ®Google Scholar
• Riihajaervi S, Taskinen M, Jerkeman M, . Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy. Eur J Haematol 2011;86:124–128.
   PubMed Web of Science ®Google Scholar
• Dreyling M, Hiddemann W, Truemper L, . Leitlinien Maligne Lymphome. Deutsche Gessellschaft fuer Haematologie und Onkologie eV Februar, 2007. Available from: http://www.dgho.de/informationen/leitlinien/lymphome/Maligne%20Lymphome.pdf
   Google Scholar
• National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Non-Hodgkin's Lymphomas v3.2011. Available from: www.nccn.org/professionals/physician_gls/pdf/nhl.pdf
   Google Scholar
• Joensson B, Wilking N. A global comparison regarding patient access to cancer drugs. Ann Oncol 2007;18(Suppl. 3):iii1–iii77.
   Google Scholar
• Berinstein NL, Grillo-Lopez AJ, White CA, . Association of serum rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 1998;9:995–1001.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Rummel MJ. Bendamustine: rebirth of an old drug. J Clin Oncol 2009;27:1492–1501.
   PubMed Web of Science ®Google Scholar
• Pulte D, Redaniel MT, Brenner H, . Changes in cancer survival by ethnicity between 1992-96 and 2002-06: are survival disparities increasing or decreasing?Ann Oncol 2012;23:2428–2434.
   PubMed Web of Science ®Google Scholar
• Collins SR, Schoen C, Kriss JL, . Rite of passage?Why young adults become uninsured and how new policies can help. Issue Brief (Commonw Fund) 2007;26:1–16.
   PubMedGoogle Scholar
• Martin S, Ulrich C, Munsell M, . Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist 2007;12:816–824.
   PubMed Web of Science ®Google Scholar
• Jansen L, Gondos A, Eberle A, . Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol 2012 Aug 22. [Epub ahead of print]
   Google Scholar
• Brenner H, Holleczek B. Deriving valid population-based cancer survival estimates in the presence of nonnegligible proportions of cancers notified by death certificate only. Cancer Epidemiol Biomarkers Prev 2011;20:2480–2486.
   PubMed Web of Science ®Google Scholar